Transcriptic

Transcriptic, established in 2012, pioneered a robotic cloud lab platform designed to revolutionize life science research. Their core innovation, the Transcriptic Common Lab Environment (TCLE), provided a scalable digital infrastructure. This platform seamlessly integrated laboratory processes, instruments, and IoT technologies into a unified user interface. This allowed researchers to conduct experiments with enhanced scalability, reproducibility, and speed, regardless of their physical location.

Leading pharmaceutical corporations and emerging biotechnology firms adopted Transcriptic's platform to improve the reproducibility and flexibility of their experimental design and execution. By harnessing cloud-based technologies, users could access a fully automated laboratory environment. This access was available either through on-premise TCLE deployments within their own facilities or via Transcriptic's Bioassays services, all managed through a user-friendly web interface.

Transcriptic aimed to transform drug discovery and synthetic biology research by enabling scientists to concentrate on accelerating scientific breakthroughs, rather than being burdened by time-consuming and labor-intensive bench work. Unfortunately, the company is now inactive.